A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2025

Conditions

Ovarian Aging

Interventions

DRUG

Yijing Keli

Once enrolled, participants will be administrated Yijing Keli

Trial Locations (1)

RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors

lead

Tongji Hospital

OTHER